GREGoRi Innovation Projects (U01 Clinical Trial Optional)
HHS-NIH11 Posted RFA-HG-27-013
Close Date:
October 30, 2026
90 days remaining
Description
The Genomics Research to Elucidate the Genetics of Rare Diseases:innovation (GREGoRi) initiative seeks to accelerate a paradigm shift in rare disease diagnosis by reimagining the tools, molecular technologies and analytical approaches used to identify the causal gene(s) and/or variant(s) underlying rare genetic disorders. This Notice of Funding Opportunity is intended to stimulate the development and testing of highly innovative experimental or computational approaches for rare disease diagnosis, that have the potential to make transformative improvements to the current state of the art.
Eligibility
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Actions
Funding Details
- Award Floor
- $3.00
- Award Ceiling
- $500,000.00
- Total Estimated Funding
- $7,500,000.00
- Expected Awards
- 10
Key Dates
- Posted
- June 18, 2026
- Closes
- October 30, 2026 90d
- Archive Date
- December 9, 2026
Agency Information
- Agency Name
- National Institutes of Health
- Agency Code
- HHS-NIH11
- Funding Instrument
- Other